1607 Capital Partners, LLC Tekla Life Sciences Investors Transaction History
1607 Capital Partners, LLC
- $1.23 Billion
- Q1 2024
A detailed history of 1607 Capital Partners, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, 1607 Capital Partners, LLC holds 481,379 shares of HQL stock, worth $6.79 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
481,379
Previous 480,179
0.25%
Holding current value
$6.79 Million
Previous $6.46 Million
1.52%
% of portfolio
0.54%
Previous 0.45%
Shares
13 transactions
Others Institutions Holding HQL
# of Institutions
80Shares Held
8.51MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.46MShares$34.7 Million0.58% of portfolio
-
Morgan Stanley New York, NY484KShares$6.83 Million0.0% of portfolio
-
Allspring Global Investments Holdings, LLC431KShares$6.08 Million0.01% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT387KShares$5.46 Million0.32% of portfolio
-
Karpus Management, Inc. Pittsford, NY346KShares$4.87 Million0.14% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...